Olga Barajas

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 1K citations · Full text

Medicine, Oncology, Pharmacology +8

The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer

Yelena Y. Janjigian, Akihito Kawazoe, Patricio Yañez et al. · Nature · 2021 · 689 citations · Full text

Medicine, Oncology, Pharmacology +17

Gallstones, Body Mass Index, C‐Reactive Protein, and Gallbladder Cancer: Mendelian Randomization Analysis of Chilean and European Genotype Data

Carol Barahona Ponce, Dominique Scherer, Regina Brinster et al. · Hepatology · 2020 · 106 citations · Full text

Medicine, Biostatistics, Preventive Medicine +16

Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction (G/GEJ) cancer: Initial findings of the global phase 3 KEYNOTE-811 study.

Yelena Y. Janjigian, Akihito Kawazoe, Patricio Yañez et al. · Journal of Clinical Oncology · 2021 · 92 citations

Medicine, Oncology, Pharmacotherapy +17

Subtypes of Native American ancestry and leading causes of death: Mapuche ancestry-specific associations with gallbladder cancer risk in Chile

Justo Lorenzo Bermejo, Felix Boekstegers, Rosa González Silos et al. · PLoS Genetics · 2017 · 66 citations · Full text

Medicine, Genetics, Oncology +14